← Back to Press Releases December 02, 2022 The ENVISION Study, an international, prospective natural history study in young children with SCN1A+ Dravet syndrome, 18-month follow-up Share Post Email Copy Link Cell-Selective Targeting and Regulation The precision gene therapies being developed at Encoded are potentially capable of targeting specific cell types or levels of expression to address a range of disease mechanisms. Learn more Cell-Selective Targeting and Regulation The precision gene therapies being developed at Encoded are potentially capable of targeting specific cell types or levels of expression to address a range of disease mechanisms. Learn more
